ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Stanford's James Zou detailed a virtual biotech running 37,000 collaborating AI agents. One of its drug designs received independent confirmation from Merck. The research offers a blueprint for connecting legacy databases to AI orchestration, challenging the one-engineer-one-agent assumption.
Tap to vote and see what everyone thinks.
Summary by ByteBrief